INDP

INDAPTUS THERAPEUTICS INC

INDP·45339J204·US·Common Stock·Healthcare - Biotechnology

INDP (INDAPTUS THERAPEUTICS INC) is held by 8 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($169,410), JANE STREET GROUP, LLC ($161,433), VANGUARD CAPITAL MANAGEMENT LLC ($100,956). Net institutional sentiment: Bullish.

8
Holders
$537,318
Total Value
89% (9)
Consensus
8 buying - 1 selling
13F: Insider & Congress: Updated regularly
INDP

Smart Money Verdict

View all
Loading verdict
Held by 8 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists none · Congress none

No recent insider, activist, or congressional trades for INDP.

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
56,470(+109.1%)$169,4100.0%-53.74%
25
New
53,811$161,4330.0%-62.00%
34
New
33,652$100,9560.0%-62.00%
33
New
13,967$41,9010.0%-62.00%
31
New
11,586$34,7580.0%-62.00%
30
Increased
8,936(+231.3%)$26,8080.0%-57.18%
21
New
478$1,4340.0%-62.00%
17
New
206,077$6180.0%-62.00%
15
Exited
0(-100.0%)$71,0130.0%+59.57%
0
INDPINDPINDAPTUS THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used